RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Quest Diagnostics EBIT 2024

Quest Diagnostics EBIT

1.52 B USD

Quest Diagnostics Dividend yield

2 %

Ticker

DGX

ISIN

US74834L1008

WKN

904533

In 2024, Quest Diagnostics's EBIT was 1.52 B USD, a 15.65% increase from the 1.32 B USD EBIT recorded in the previous year.

The Quest Diagnostics EBIT history

YEAREBIT (undefined USD)
2028e1.88
2027e1.78
2026e1.72
2025e1.61
2024e1.52
20231.32
20221.52
20212.5
20201.99
20191.32
20181.23
20171.27
20161.24
20151.1
20141.03
20131.12
20121.32
20111.3
20101.32
20091.35
20081.22
20071.09
20061.13
20051.01
20040.88

Quest Diagnostics Aktienanalyse

What does Quest Diagnostics do?

Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Quest Diagnostics's EBIT

Quest Diagnostics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Quest Diagnostics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Quest Diagnostics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Quest Diagnostics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Quest Diagnostics Stock

How much did Quest Diagnostics achieve in EBIT for the current year?

In the current year, Quest Diagnostics has achieved an EBIT of 1.52 B USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Quest Diagnostics.

How has the EBIT of Quest Diagnostics developed in recent years?

The EBIT of Quest Diagnostics has increased by 15.653% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Quest Diagnostics?

The EBIT of Quest Diagnostics is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Quest Diagnostics pay?

Over the past 12 months, Quest Diagnostics paid a dividend of 2.79 USD . This corresponds to a dividend yield of about 2 %. For the coming 12 months, Quest Diagnostics is expected to pay a dividend of 3.12 USD.

What is the dividend yield of Quest Diagnostics?

The current dividend yield of Quest Diagnostics is 2 %.

When does Quest Diagnostics pay dividends?

Quest Diagnostics pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Quest Diagnostics?

Quest Diagnostics paid dividends every year for the past 25 years.

What is the dividend of Quest Diagnostics?

For the upcoming 12 months, dividends amounting to 3.12 USD are expected. This corresponds to a dividend yield of 2.24 %.

In which sector is Quest Diagnostics located?

Quest Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quest Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quest Diagnostics from 4/22/2024 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 4/5/2024.

When did Quest Diagnostics pay the last dividend?

The last dividend was paid out on 4/22/2024.

What was the dividend of Quest Diagnostics in the year 2023?

In the year 2023, Quest Diagnostics distributed 2.6 USD as dividends.

In which currency does Quest Diagnostics pay out the dividend?

The dividends of Quest Diagnostics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Quest Diagnostics

Our stock analysis for Quest Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quest Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.